Federated Hermes, Inc. Genmab A/S Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$35.27 - $42.24 $282 - $337	8 Added 0.17%	4,686 $165,000
Q2 2023 Aug 14, 2023	SELL	$37.4 - $42.94 $1.29 Million - $1.48 Million	-34,360 Reduced 88.02%	4,678 $177,000
Q1 2023 May 08, 2023	SELL	$34.88 - $43.22 $22.5 Million - $27.9 Million	-645,540 Reduced 94.3%	39,038 $1.47 Million
Q4 2022 Feb 13, 2023	BUY	$33.8 - $47.06 $4.06 Million - $5.65 Million	119,990 Added 21.25%	684,578 $29 Million
Q3 2022 Nov 14, 2022	SELL	$31.52 - $373.61 $414,330 - $4.91 Million	-13,145 Reduced 2.28%	564,588 $18.1 Million
Q2 2022 Aug 15, 2022	SELL	$26.83 - $38.57 $2.3 Million - $3.3 Million	-85,682 Reduced 12.92%	577,733 $18.8 Million
Q1 2022 May 13, 2022	SELL	$30.95 - $39.68 $820,917 - $1.05 Million	-26,524 Reduced 3.84%	663,415 $24 Million
Q4 2021 Feb 14, 2022	BUY	$35.87 - $47.12 $31,493 - $41,371	878 Added 0.13%	689,939 $27.3 Million
Q3 2021 Nov 15, 2021	SELL	$41.55 - $48.72 $272,609 - $319,651	-6,561 Reduced 0.94%	689,061 $30.1 Million
Q2 2021 Aug 16, 2021	SELL	$32.88 - $44.57 $7.2 Million - $9.76 Million	-218,948 Reduced 23.94%	695,622 $28.4 Million
Q1 2021 May 13, 2021	SELL	$30.92 - $44.4 $3.46 Million - $4.97 Million	-112,008 Reduced 10.91%	914,570 $30 Million
Q4 2020 Feb 12, 2021	SELL	$33.66 - $40.76 $5,755 - $6,969	-171 Reduced 0.02%	1,026,578 $41.7 Million
Q3 2020 Nov 12, 2020	BUY	$33.07 - $38.68 $42,561 - $49,781	1,287 Added 0.13%	1,026,749 $37.6 Million
Q2 2020 Aug 13, 2020	SELL	$20.05 - $33.89 $767,614 - $1.3 Million	-38,285 Reduced 3.6%	1,025,462 $34.8 Million
Q1 2020 May 13, 2020	SELL	$17.15 - $25.22 $1.23 Million - $1.81 Million	-71,694 Reduced 6.31%	1,063,747 $22.5 Million
Q4 2019 Feb 14, 2020	BUY	$18.88 - $24.14 $2.92 Million - $3.74 Million	154,900 Added 15.8%	1,135,441 $25.4 Million
Q3 2019 Nov 14, 2019	BUY	$18.0 - $21.38 $17.6 Million - $21 Million	980,541 New	980,541 $19.9 Million

Others Institutions Holding GMAB

# of Institutions

236

Shares Held

52.5M

Call Options Held

10.2K

Put Options Held

25.5K

Alliancebernstein L.P. New York, NY

15.1M
Shares

$312 Million
0.13% of portfolio
Black Rock Inc. New York, NY

5.08M
Shares

$105 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

4.42M
Shares

$91 Million
0.02% of portfolio
Harding Loevner LP Bridgewater, NJ

3.07M
Shares

$63.1 Million
0.44% of portfolio
Wellington Management Group LLP Boston, MA

2.31M
Shares

$47.5 Million
0.01% of portfolio

View Full List

About GENMAB A/S

Ticker GMAB
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 658,292,992
Market Cap $13.6B
Description
Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; ofatumurnab, a human monoclonal antibody to treat chronic lymphoc...

More about GMAB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account